


SYNthesis BioVentures Revenue
Investment Management • Melbourne, Victoria, Australia • 1-10 Employees
SYNthesis BioVentures revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Investment Management industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at SYNthesis BioVentures
Andrew Wilks
Managing Director
Company overview
| Headquarters | Melbourne, Victoria, Australia |
| Website | |
| NAICS | 5231 |
| Founded | 2022 |
| Employees | 1-10 |
About SYNthesis BioVentures
We believe that Australian research is among the best in the world, yet there is a market failure at the heart of the Australian biotech market. SYNthesis BioVentures manages a fund (SYNthesis Bioventures Fund I) focused on early stage therapeutics, investing in projects from discovery through preclinical proof of concept and IND-enabling studies. We invest in small molecule therapeutics, biologics, and cell and gene therapies for indications with significant unmet need. By investing in projects from inception through to pre-IPO, we intend to facilitate the continuity of capital from Australian academia to venture financing and through Australian capital markets.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
SYNthesis BioVentures has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
SYNthesis BioVentures has never raised funding before.
SYNthesis BioVentures Tech Stack
Discover the technologies and tools that power SYNthesis BioVentures's digital infrastructure, from frameworks to analytics platforms.
Form builders
Web servers
Tag managers
JavaScript libraries
Miscellaneous
Programming languages
Miscellaneous
JavaScript libraries
WordPress plugins
Blogs
JavaScript libraries
Security
Frequently asked questions
4.8
40,000 users



